第三阶段多发性骨髓瘤临床试验的后续持续时间:系统性审查
Mohammad O Ali1, Hafez M Abdullah1, Khaldun Obeidat2
1Department of Internal Medicine Sanford School of Medicine University of South Dakota Sioux Falls South Dakota USA.
EJHaem
|August 21, 2023
概括
长期随访对于多发性骨髓瘤 (MM) 临床试验至关重要. 目前的III期试验的随访时间很短,这阻碍了对患者长期结果的评估.
科学领域:
- 血液学 血液学 血液学
- 临床试验 研究 研究 临床试验 临床试验
- 在瘤学瘤学.
背景情况:
- 长期跟踪对于评估临床试验中治疗效果的持久性至关重要.
- 多发性骨髓瘤 (MM) 是一种具有不断变化的治疗景观的血液性恶性瘤.
研究的目的:
- 调查多发性骨髓瘤 (MM) 的III期临床试验中随访的持续时间.
- 评估当前的随访期在改善患者治疗结果的背景下是否足够.
主要方法:
- 对多发性骨髓瘤的III期临床试验的系统审查.
- 对不同患者群体 (新诊断与复发/耐药) 报告的中位随访持续时间的分析.
主要成果:
- 新诊断的MM试验的中位数随访时间为42.7个月.
- 复发性/耐药性MM试验的中位随访时间为20.5个月.
- 鉴于目前的治疗进展,随访时间被认为相对较短.
结论:
- 多发性骨髓瘤的III期临床试验往往没有足够的随访期.
- 需要加强长期随访协议和MM临床试验报告.
- 促进扩展后续行动和及时公布最新结果对于全面的结果评估至关重要.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Drug Administration and Therapy Phases: Overview
532
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
532
Assumptions of Survival Analysis
154
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
154
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


